Healthcare & Life Sciences

From “green” chemicals to carbon-neutral cement, the power of microbes to make industrial materials could play a key role in the transition away from fossil fuels. Brunswick’s Ben Hirschler reports.

As a practical matter, long-term success demands ESG discipline, says Dr. Jeane Tsutsui, CEO of Brazilian medical diagnostics company Grupo Fleury. She speaks with Brunswick’s Roberta Lippi and Daniel Wiedemann about her journey.

How are companies deploying AI to advance sustainability priorities and create social value?

“We’re building a world where doctors spend more time looking their patients in the eye,” says Lucy Orr-Ewing, Head of Policy at the Coalition for Health AI.

Not waiting for nature-positive standards, UK multinational GSK is taking action and a leadership role in the pharma and biotech sector. By Alastair Morton and Ellie Fallon.

From handling mental illness, the business focus has switched to creating mental health. Poppy Jaman OBE, CEO of the City Mental Health Alliance, speaks to Brunswick’s Ann-Kathrin Richter about her life’s work.

One state’s readiness could serve as a model for the nation and the world. “Coronavirus Slayer” K.K. Shailaja, Kerala’s Health Minister, talks to Brunswick’s Khozem Merchant.

CIO Fletcher Previn and his team “compressed 10 years of strategy into 10 weeks of execution,” reports Philip Delves Broughton.

One legacy of the pandemic is the arrival in general parlance of “WFH.” So named, this edition of our magazine brings you Brunswick Review stories posted online during the first months of the pandemic.

Two Stanford Medicine leaders on AI’s potential, and what realizing it will require. By Courtney Chiang Dorman and Kate Larsen.

At the intersection of technology, research and clinical care stands Verily’s Amy Abernethy. By Tanisha Carino and Jennifer Sukawaty.

As the climate crisis deepens, Stanford Medicine is leveraging science and smart working practices to counter the threat to health. By Ben Hirschler and Jennifer Sukawaty.